• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling.利用合成肽和计算机建模对前列腺特异性抗原(PSA)和人腺体激肽释放酶2(hK2)的抗原表位进行测定和分析。
Protein Sci. 1998 Feb;7(2):259-69. doi: 10.1002/pro.5560070205.
2
Immunoreactivity of recombinant human glandular kallikrein using monoclonal antibodies raised against prostate-specific antigen.使用针对前列腺特异性抗原产生的单克隆抗体对重组人腺激肽释放酶进行免疫反应性检测。
Prostate. 1997 May 1;31(2):84-90. doi: 10.1002/(sici)1097-0045(19970501)31:2<84::aid-pros2>3.0.co;2-h.
3
Cross-reactivity of ten anti-prostate-specific antigen monoclonal antibodies with human glandular kallikrein.十种抗前列腺特异性抗原单克隆抗体与人腺体激肽释放酶的交叉反应性。
Urology. 1997 Oct;50(4):567-71; discussion 571-2. doi: 10.1016/S0090-4295(97)00415-9.
4
Polyclonal and monoclonal antibodies to prostate-specific antigen can cross-react with human kallikrein 2 and human kallikrein 1.针对前列腺特异性抗原的多克隆抗体和单克隆抗体可与人激肽释放酶2和人激肽释放酶1发生交叉反应。
Urology. 1999 Apr;53(4):746-51. doi: 10.1016/s0090-4295(98)00573-1.
5
Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling.利用分子建模对前列腺特异性抗原和人腺体激肽释放酶进行结构比较。
Urology. 1995 May;45(5):801-6. doi: 10.1016/S0090-4295(99)80087-9.
6
Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity.人腺激肽释放酶(hK2)特异性单克隆抗体的研制:一种对前列腺特异性抗原交叉反应可忽略不计的hK2双抗体免疫测定法的研制
Urology. 1998 May;51(5):804-9. doi: 10.1016/s0090-4295(98)00107-1.
7
Epitope analysis of a prostate-specific antigen (PSA) C-terminal-specific monoclonal antibody and new aspects for the discrepancy between equimolar and skewed PSA assays.前列腺特异性抗原(PSA)C末端特异性单克隆抗体的表位分析以及等摩尔和偏态PSA检测结果差异的新情况
Clin Chem. 1999 Apr;45(4):486-96.
8
Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum.用于灵敏且特异测定血清中人前列腺腺激肽释放酶(hK2)的免疫荧光测定法。
Clin Chem. 1996 Jul;42(7):1034-41.
9
A structural model for the prostate disease marker, human prostate-specific antigen.前列腺疾病标志物——人前列腺特异性抗原的结构模型
Protein Sci. 1994 Nov;3(11):2033-44. doi: 10.1002/pro.5560031116.
10
Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivity.重组前列腺特异性抗原(PSA)和己糖激酶2(HK2)的制备及其免疫交叉反应性分析。
Biochem Biophys Res Commun. 1995 Aug 24;213(3):888-95. doi: 10.1006/bbrc.1995.2212.

引用本文的文献

1
Designed ankyrin repeat proteins for detecting prostate-specific antigen expression .设计用于检测前列腺特异性抗原表达的锚蛋白重复序列蛋白。
RSC Chem Biol. 2023 May 17;4(7):494-505. doi: 10.1039/d3cb00010a. eCollection 2023 Jul 5.
2
Targeting Tumor Markers with Antisense Peptides: An Example of Human Prostate Specific Antigen.靶向肿瘤标志物的反义肽:以人前列腺特异性抗原为例。
Int J Mol Sci. 2019 Apr 28;20(9):2090. doi: 10.3390/ijms20092090.
3
Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.使用靶向游离前列腺特异性抗原的放射性示踪剂对雄激素受体信号进行成像。
Cancer Discov. 2012 Apr;2(4):320-7. doi: 10.1158/2159-8290.CD-11-0316. Epub 2012 Mar 31.
4
Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.利用针对游离前列腺特异性抗原上独特表位的单克隆抗体,针对游离前列腺特异性抗原进行体内前列腺癌成像的靶向。
Cancer Biother Radiopharm. 2012 May;27(4):243-51. doi: 10.1089/cbr.2011.1088. Epub 2012 Apr 10.
5
Three genes expressing Kunitz domains in the epididymis are related to genes of WFDC-type protease inhibitors and semen coagulum proteins in spite of lacking similarity between their protein products.在附睾中表达 Kunitz 结构域的三个基因与 WFDC 型蛋白酶抑制剂基因和精液凝块蛋白基因有关,尽管它们的蛋白质产物之间没有相似性。
BMC Biochem. 2011 Oct 11;12:55. doi: 10.1186/1471-2091-12-55.
6
The epitope space of the human proteome.人类蛋白质组的表位空间。
Protein Sci. 2008 Apr;17(4):606-13. doi: 10.1110/ps.073347208.

本文引用的文献

1
Epitope mapping of human prostate specific antigen and glandular kallikrein expressed in insect cells.在昆虫细胞中表达的人前列腺特异性抗原和腺激肽释放酶的表位作图
Prostate Cancer Prostatic Dis. 1997 Sep;1(1):16-20. doi: 10.1038/sj.pcan.4500206.
2
Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins.丝氨酸蛋白酶抑制剂-蛋白酶复合物的结构解析揭示了丝氨酸蛋白酶抑制剂的抑制机制。
Nat Struct Biol. 1997 May;4(5):354-7. doi: 10.1038/nsb0597-354.
3
The serpin-proteinase complex revealed.已揭示的丝氨酸蛋白酶抑制剂-蛋白酶复合物
Nat Struct Biol. 1997 May;4(5):339-41. doi: 10.1038/nsb0597-339.
4
Immunoreactivity of recombinant human glandular kallikrein using monoclonal antibodies raised against prostate-specific antigen.使用针对前列腺特异性抗原产生的单克隆抗体对重组人腺激肽释放酶进行免疫反应性检测。
Prostate. 1997 May 1;31(2):84-90. doi: 10.1002/(sici)1097-0045(19970501)31:2<84::aid-pros2>3.0.co;2-h.
5
Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.前列腺特异性抗原(PSA)的抗原决定簇及针对不同形式PSA的检测方法的开发
Br J Cancer. 1997;75(6):789-97. doi: 10.1038/bjc.1997.142.
6
Major proteinase movement upon stable serpin-proteinase complex formation.稳定的丝氨酸蛋白酶抑制剂-蛋白酶复合物形成时主要蛋白酶的移动
Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):453-8. doi: 10.1073/pnas.94.2.453.
7
Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer.血清中不同前列腺特异性抗原形式分析用于检测临床局限性前列腺癌的比较。
Urology. 1996 Dec;48(6):882-8. doi: 10.1016/s0090-4295(96)00486-4.
8
Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building.通过比较模型构建对α-1-抗糜蛋白酶:前列腺特异性抗原复合物进行结构研究。
Protein Sci. 1996 May;5(5):836-51. doi: 10.1002/pro.5560050505.
9
Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum.用于灵敏且特异测定血清中人前列腺腺激肽释放酶(hK2)的免疫荧光测定法。
Clin Chem. 1996 Jul;42(7):1034-41.
10
Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma.在人类精浆中分离前列腺激肽释放酶hK2,也称为hGK-1。
Biochim Biophys Acta. 1995 Dec 14;1245(3):311-6. doi: 10.1016/0304-4165(95)00118-2.

利用合成肽和计算机建模对前列腺特异性抗原(PSA)和人腺体激肽释放酶2(hK2)的抗原表位进行测定和分析。

Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling.

作者信息

Piironen T, Villoutreix B O, Becker C, Hollingsworth K, Vihinen M, Bridon D, Qiu X, Rapp J, Dowell B, Lövgren T, Pettersson K, Lilja H

机构信息

Department of Biotechnology, University of Turku, Finland.

出版信息

Protein Sci. 1998 Feb;7(2):259-69. doi: 10.1002/pro.5560070205.

DOI:10.1002/pro.5560070205
PMID:9521101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2143911/
Abstract

Prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2), produced essentially by the prostate gland, are 237-amino acid monomeric proteins, with 79% identity in primary structure. Twenty-five anti-PSA monoclonal antibodies (Mabs) were studied for binding to a large array of synthetic linear peptides selected from computer models of PSA and hK2, as well as to biotinylated peptides covering the entire PSA sequence. Sixteen of the Mabs were bound to linear peptides forming four independent binding regions (I-IV). Binding region I was localized to amino acid residues 1-13 (identical sequence for PSA and hK2), II (a and b) was localized to residues 53-64, III (a and b) was localized to residues 80-91 (= kallikrein loop), and IV was localized to residues 151-164. Mabs binding to regions I and IIa were reactive with free PSA, PSA-ACT complex, and with hK2; Mabs binding to regions IIb, IIIa, and IV were reactive with free PSA and PSA-ACT complex, but unreactive with hK2; Mabs binding to region IIIb detected free PSA only. All Mabs tested (n = 7) specific for free PSA reacted with kallikrein loop (binding region IIIb). The presence of Mabs interacting with binding region I did not inhibit the catalytic activity of PSA, whereas Mabs interacting with other binding regions inhibited the catalysis. Theoretical model structures of PSA, hK2, and the PSA-ACT complex were combined with the presented data to suggest an overall orientation of PSA with regard to ACT.

摘要

前列腺特异性抗原(PSA)和人腺体激肽释放酶2(hK2)主要由前列腺产生,是237个氨基酸的单体蛋白,一级结构具有79%的同源性。研究了25种抗PSA单克隆抗体(Mab)与从PSA和hK2的计算机模型中选择的大量合成线性肽以及覆盖整个PSA序列的生物素化肽的结合情况。其中16种Mab与线性肽结合,形成四个独立的结合区域(I-IV)。结合区域I定位于氨基酸残基1-13(PSA和hK2的相同序列),II(a和b)定位于残基53-64,III(a和b)定位于残基80-91(=激肽释放酶环),IV定位于残基151-164。与区域I和IIa结合的Mab与游离PSA、PSA-ACT复合物以及hK2反应;与区域IIb、IIIa和IV结合的Mab与游离PSA和PSA-ACT复合物反应,但与hK2无反应;与区域IIIb结合的Mab仅检测到游离PSA。所有测试的针对游离PSA的Mab(n = 7)均与激肽释放酶环(结合区域IIIb)反应。与结合区域I相互作用的Mab的存在不抑制PSA的催化活性,而与其他结合区域相互作用的Mab则抑制催化作用。将PSA、hK2和PSA-ACT复合物的理论模型结构与所呈现的数据相结合,以表明PSA相对于ACT的总体取向。